Amneal Pharmaceuticals, Inc. (AMRX)
14.50
-0.10
(-0.68%)
USD |
NASDAQ |
Feb 20, 16:00
14.53
+0.03
(+0.21%)
After-Hours: 20:00
Amneal Pharmaceuticals Research and Development Expense (Quarterly) : 63.35M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 68.85M |
| Pfizer Inc. | 3.206B |
| Apellis Pharmaceuticals, Inc. | 68.19M |
| Nektar Therapeutics | 27.25M |
| Innoviva, Inc. | 13.67M |